These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 2892260

  • 1. Nizatidine versus ranitidine in the prevention of duodenal ulcer relapse. Six-month interim results of a European multicentre study.
    Hentschel E, Schütze K, Reichel W, Kerstan E, Kratochvil P, Brandstätter G, Judmaier G, Keohane PP.
    Scand J Gastroenterol Suppl; 1987; 136():84-8. PubMed ID: 2892260
    [Abstract] [Full Text] [Related]

  • 2. 300 mg nizatidine at night versus 300 mg ranitidine at night in patients with duodenal ulcer. A multicentre trial in Europe.
    Simon B, Cremer M, Dammann HG, Hentschel E, Keohane PP, Mulder H, Müller P, Sarles H.
    Scand J Gastroenterol Suppl; 1987; 136():61-70. PubMed ID: 2892257
    [Abstract] [Full Text] [Related]

  • 3. Nizatidine as maintenance therapy of duodenal ulcer disease in remission.
    Cerulli MA, Cloud ML, Offen WW, Chernish SM, Matsumoto C.
    Scand J Gastroenterol Suppl; 1987; 136():79-83. PubMed ID: 2892259
    [Abstract] [Full Text] [Related]

  • 4. Nizatidine versus ranitidine in the treatment of peptic ulcer disease: report on the Dutch investigation as part of a European multicentre trial.
    Kuipers EJ, Hazenberg HJ, Quik RF, Hazenberg BP, de Zwart PA.
    Neth J Med; 1990 Aug; 37(1-2):58-62. PubMed ID: 1977089
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Nizatidine and ranitidine in the short-term treatment of duodenal ulcer: a cooperative double-blind study of once-daily bedtime administration.
    Pace F, Colombo E, Ferrara A, Prada A, Rocca F, Bianchi Porro G.
    Am J Gastroenterol; 1988 Jun; 83(6):643-5. PubMed ID: 2897784
    [Abstract] [Full Text] [Related]

  • 7. [Nizatidine versus ranitidine in the treatment of acute duodenal ulcer. Comparison of 300 mg nizatidine and 300 mg ranitidine in a single evening dose].
    Arnold R, Beckenbach P, Bock H, Bormann R, Daake H, Dammann HG, Du Bosque G, Fürer M, Geiter B, Hebbeln H.
    Fortschr Med; 1989 Jul 20; 107(21):467-70. PubMed ID: 2570012
    [Abstract] [Full Text] [Related]

  • 8. Nizatidine in the short-term treatment of duodenal ulcer--an Italian Multicenter Study.
    Bovero E, Poletti M, Boero A, Mura BC, Camarri E, Corradini P, Corsini G, Federici G, Curzio M, Gianquinto G.
    Hepatogastroenterology; 1987 Dec 20; 34(6):269-71. PubMed ID: 2892768
    [Abstract] [Full Text] [Related]

  • 9. The effect of an oral morning dose of nizatidine and ranitidine on gastric acid secretion in duodenal ulcer patients.
    Lazzaroni M, Bianchi Porro G.
    Hepatogastroenterology; 1989 Dec 20; 36(6):490-3. PubMed ID: 2575571
    [Abstract] [Full Text] [Related]

  • 10. A comparison of nizatidine and ranitidine in the maintenance treatment of duodenal ulcer. A randomized, double blind, multicentre, 2-year study.
    Di Mario F, Battaglia G, Saggioro A, Chiozzini P, D'Angelo A, Marin R, Morelli A, Vezzadini P, Buscarini L, Cavassini G.
    Ital J Gastroenterol; 1991 Jun 20; 23(5):253-6. PubMed ID: 1742515
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A multicenter, randomized, double-blind study comparing famotidine with ranitidine in the treatment of active duodenal ulcer disease.
    McCullough AJ.
    Am J Med; 1986 Oct 24; 81(4B):17-24. PubMed ID: 2877570
    [Abstract] [Full Text] [Related]

  • 13. Comparison of 150 mg nizatidine BID or 300 mg at bedtime, and 150 mg ranitidine BID in the treatment of gastric ulcer--an 8-week randomized, double-blind multicentre study.
    Di Mario F, Battaglia G, Naccarato R, D'Angelo A, Saggioro A, Da Broi GL, Vezzadini P, Bianchi Porro G.
    Hepatogastroenterology; 1990 Dec 24; 37 Suppl 2():62-5. PubMed ID: 1982108
    [Abstract] [Full Text] [Related]

  • 14. Ebrotidine versus ranitidine in the healing and prevention of relapse of duodenal ulcer. A multicentre, double-blind, parallel, randomized, controlled study.
    Tulassay Z, Döbrönte Z, Farkas I, Juhász L, Simon L, Prónai L, Torres J, Márquez M.
    Arzneimittelforschung; 1997 Apr 24; 47(4A):551-5. PubMed ID: 9205763
    [Abstract] [Full Text] [Related]

  • 15. Ranitidine and cimetidine in prevention of duodenal ulcer relapse. A double-blind, randomised, multicentre, comparative trial.
    Gough KR, Korman MG, Bardhan KD, Lee FI, Crowe JP, Reed PI, Smith RN.
    Lancet; 1984 Sep 22; 2(8404):659-62. PubMed ID: 6147693
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Prevention of duodenal ulcer relapse with ranitidine.
    Mekel RC, den Boer DJ.
    S Afr Med J; 1985 Sep 14; 68(6):385-6. PubMed ID: 3898417
    [Abstract] [Full Text] [Related]

  • 19. Famotidine versus ranitidine for the short-term treatment of duodenal ulcer.
    Simon B, Dammann HG, Jakob G, Miederer SE, Müller P, Ottenjann R, Paul F, Scholten T, Schütz E, Seifert E.
    Digestion; 1985 Sep 14; 32 Suppl 1():32-7. PubMed ID: 2866134
    [Abstract] [Full Text] [Related]

  • 20. Nizatidine: a new histamine receptor blocker in the treatment of active duodenal ulcers.
    Levendoglu H, Mehta B, Wait C, Reddy G, Hatcher C.
    Am J Gastroenterol; 1986 Dec 14; 81(12):1167-70. PubMed ID: 2878607
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.